B. Breit, C. U. Grünanger, O. Abillard
FULL PAPER
7.2 Hz, 1 H), 6.89–6.97 (m, 1 H), 7.22–7.42 (m, 12 H), 7.95–8.01
(m, 1 H), 9.60 (d, J = 2.0 Hz, 1 H) ppm. 13C NMR (100.6 MHz,
CDCl3): δ = 11.3, 19.1, 52.3, 62.7, 128.4, 128.6 (2 C), 128.6 (2 C),
3-(tert-Butyldiphenylsilyl)-2-formylpropyl o-(Diphenylphosphanyl)-
benzoate (15): According to GP 1, hydroformylation of 5 (205 mg,
0.351 mmol) was carried out with [Rh(CO)2acac] (0.6 mg, 2 µmol)
in toluene (4 mL), giving 15 (188 mg, 87%). 1H NMR (400.1 MHz,
CDCl3): δ = 1.04 (s, 9 H), 1.19 (dd, J = 15.5, 6.8 Hz, 1 H), 1.60
(dd, J = 15.3, 6.6 Hz, 1 H), 2.60 (ddddd, J = 6.5, 6.5, 6.5, 5.1,
128.8 (2 C), 130.8 (d, JC,P = 2.9 Hz), 132.2, 133.9 (d, JC,P
20.5 Hz, 4 C), 134.0 (d, JC,P = 19.3 Hz), 134.5, 137.9 (d, JC,P
=
=
11.1 Hz), 137.9 (d, JC,P = 11.1 Hz), 140.6 (d, JC,P = 26.8 Hz), 166.6
(d, JC,P = 2.2 Hz), 202.4 ppm. 31P NMR (162.0 MHz, CDCl3): δ = 1.4 Hz, 1 H), 4.08 (dd, J = 11.3, 6.4 Hz, 1 H), 4.11 (dd, J = 11.3,
–4.6 ppm. C24H23O3P (390.1): calcd. C 73.83, H 5.94; found C
73.96, H 5.91.
4.9 Hz, 1 H), 6.88–6.95 (m, 1 H), 7.15–7.45 (m, 18 H), 7.55–7.61
(m, 4 H), 7.90–7.95 (m, 1 H), 9.24 (d, J = 1.5 Hz, 1 H) ppm. 13C
NMR (100.6 MHz, CDCl3): δ = 5.8, 18.3, 27.8 (3 C), 46.8, 64.9,
128.0 (4 C), 128.4, 128.5 (2 C), 128.6 (2 C), 128.7 (d, JC,P = 2.2 Hz,
2 C), 129.7, 129.7, 130.8 (d, JC,P = 2.9 Hz), 132.2, 133.4, 133.6,
133.9 (d, JC,P = 20.8 Hz, 2 C), 133.9 (d, JC,P = 20.8 Hz, 2 C), 134.1
(d, JC,P = 19.6 Hz), 134.5, 136.0 (2 C), 136.1 (2 C), 137.9 (d, JC,P
= 11.3 Hz), 137.9 (d, JC,P = 11.3 Hz), 140.5 (d, JC,P = 27.0 Hz),
166.3 (d, JC,P = 1.9 Hz), 202.0 ppm. 31P NMR (162.0 MHz,
CDCl3): δ = –4.9 ppm. C39H39O3PSi (614.78): calcd. C 76.19, H
6.39; found C 76.48, H 6.39.
2-Formylpropyl o-(Diphenylphosphanyl)benzoate (12): According to
GP 1, hydroformylation of 1 (208 mg, 0.600 mmol) was carried out
with [Rh(CO)2acac] (1.1 mg, 4.2 µmol) in toluene (6 mL), giving 12
1
(226 mg, quant.). H NMR (400.1 MHz, CDCl3): δ = 1.13 (d, J =
7.1 Hz, 3 H), 2.69 (dddq, J = 7.0, 7.0, 5.4, 1.4 Hz, 1 H), 4.37 (dd,
J = 11.3, 5.2 Hz, 1 H), 4.43 (dd, J = 11.2, 6.8 Hz, 1 H), 6.92–6.99
(m, 1 H), 7.16–7.45 (m, 12 H), 7.98–8.06 (m, 1 H), 9.64 (d, J =
1.3 Hz, 1 H) ppm. 13C NMR (100.6 MHz, CDCl3): δ = 10.7, 45.7,
64.4, 128.4, 128.6 (2 C), 128.6 (2 C), 128.8 (2 C), 130.8 (d, JC,P
2.9 Hz), 132.2, 133.9 (d, JC,P = 20.5 Hz, 2 C), 134.0 (d, JC,P
20.8 Hz, 2 C), 134.0 (d, JC,P = 19.3 Hz), 134.5, 137.8 (d, JC,P
=
=
=
2- and 3-Formyl-3-phenylpropyl o-(Diphenylphosphanyl)benzoate
(16): Owing to the reduced reactivity of the starting material 6 in
the hydroformylation reaction the GP 2, featuring a higher catalyst
loading and a lower concentration of the o-DPPB ester, was em-
ployed. Hydroformylation of 6 (205 mg, 0.332 mmol) was carried
out with [Rh(CO)2acac] (1.5 mg, 6.0 µmol, 1.8 mol-%) in toluene
(10 mL, 0.03 ), giving 16 (149 mg, 99%). 2-Formyl-3-phenylpro-
pyl o-(diphenylphosphanyl)benzoate: 1H NMR (400.1 MHz,
CDCl3): δ = 2.76 (dd, J = 13.9, 7.8 Hz, 1 H), 2.90 (ddddd, J = 7.6,
6.2, 6.0, 5.5, 1.5 Hz, 1 H), 3.04 (dd, J = 13.9, 6.4 Hz, 1 H), 4.37–
4.40 (m, 2 H), 6.91–6.97 (m, 1 H)*, 7.09–7.15 (m, 2 H)*, 7.20–7.43
(m, 15 H)*, 7.94–7.99 (m, 1 H)*, 9.67 (d, J = 1.4 Hz, 1 H) ppm.
3-Formyl-3-phenylpropyl o-(diphenylphosphanyl)benzoate: 1H
NMR (400.1 MHz, CDCl3): δ = 1.95 (dddd, J = 14.4, 8.7, 5.7,
5.7 Hz, 1 H), 2.39 (dddd, J = 14.4, 8.2, 6.0, 6.0 Hz, 1 H), 3.55 (dd,
J = 8.7, 6.0 Hz, 1 H), 4.09 (ddd, J = 11.2, 8.1, 5.5 Hz, 1 H), 4.20
(ddd, J = 11.3, 5.8, 5.8 Hz, 1 H), 6.91–6.97 (m, 1 H)*, 7.09–7.15
(m, 2 H)*, 7.20–7.43 (m, 15 H)*, 7.94–7.99 (m, 1 H)*, 9.59 (d, J =
1.1 Hz, 1 H) ppm. *Signals overlapping with those of the other
isomer. 13C NMR (100.6 MHz, CDCl3) of the mixture of regioiso-
mers (doubled signal set): δ = 28.6, 32.0, 52.4, 55.8, 62.6, 62.8,
126.8, 127.9, 128.4, 128.4, 128.5 (2 C), 128.6 (2 C), 128.6 (2 C),
128.6 (2 C), 128.7 (d, JC,P = 4.8 Hz, 2 C), 128.7 (d, JC,P = 4.8 Hz,
2 C), 128.8 (2 C), 129.0 (2 C), 129.1 (2 C), 129.3 (2 C), 130.7 (d,
JC,P = 2.7 Hz), 130.8 (d, JC,P = 2.4 Hz), 132.1, 132.3, 133.9 (d, JC,P
11.1 Hz, 2 C), 140.5 (d, JC,P = 26.8 Hz), 166.6 (d, JC,P = 1.9 Hz),
202.1 ppm. 31P NMR (162.0 MHz, CDCl3):
δ
=
–4.6 ppm.
C23H21O3P (376.4): calcd. C 73.39, H 5.62; found C 73.16, H 5.60.
3- and 4-Formylbutyl o-(Diphenylphosphanyl)benzoate (13): Accord-
ing to GP 1, hydroformylation of 2 (216 mg, 0.600 mmol) was car-
ried out with [Rh(CO)2acac] (1.1 mg, 4.2 µmol) in toluene (6 mL),
giving 13 (208 mg, 89%). Major regioisomer [3-formylbutyl o-(di-
phenylphosphanyl)benzoate, 58%]: 1H NMR (400.1 MHz, CDCl3):
δ = 1.07 (d, J = 7.1 Hz, 3 H), 2.05 (dqd, J = 7.1, 7.0, 6.8 Hz, 1 H),
2.33–2.42 (m, 2 H)*, 4.24 (ddd, J = 6.8, 6.0, 1.9 Hz, 2 H), 6.90–
6.95 (m, 1 H)*, 7.22–7.44 (m, 12 H)*, 8.98–8.06 (m, 1 H)*, 9.56 (d,
J = 1.3 Hz, 1 H) ppm. 13C NMR (100.6 MHz, CDCl3): δ = 13.2,
28.0, 43.4, 62.7, 128.4, 128.5 (2 C), 128.6 (2 C), 128.7 (2 C), 130.7
(d, JC,P = 3.1 Hz), 132.0, 134.0 (d, JC,P = 20.5 Hz, 4 C), 134.5,
134.5 (d, JC,P = 19.5 Hz), 137.9 (d, JC,P = 11.1 Hz, 2 C), 140.2 (d,
JC,P = 26.3 Hz), 167.0 (d, JC,P = 1.9 Hz), 203.9 ppm. 31P NMR
(162.0 MHz, CDCl3): δ = –4.7 ppm. Minor regioisomer [4-for-
mylbutyl o-(diphenylphosphanyl)benzoate, 42%]: 1H NMR
(400.1 MHz, CDCl3): δ = 1.55–1.65 (m, 4 H), 2.33–2.42 (m, 2 H)*,
4.18 (tt, J = 4.0, 2.0 Hz, 2 H), 6.90–6.95 (m, 1 H)*, 7.22–7.44 (m,
12 H)*, 8.98–8.06 (m, 1 H)*, 9.73 (t, J = 1.6 Hz, 1 H) ppm. 13C
NMR (100.6 MHz, CDCl3): δ = 18.7, 29.2, 43.4, 64.7, 128.4, 128.6
(2 C), 128.6 (2 C), 128.8 (2 C), 130.7 (d, JC,P = 2.7 Hz), 132.1,
134.0 (d, JC,P = 20.5 Hz, 4 C), 134.5, 134.7 (d, JC,P = 19.5 Hz),
138.0 (d, JC,P = 10.9 Hz, 2 C), 140.2 (d, JC,P = 26.3 Hz), 167.0 (d,
JC,P = 2.2 Hz), 202.1 ppm. 31P NMR (162.0 MHz, CDCl3): δ =
–4.6 ppm. *Signals overlapping with those of the other isomer.
C24H23O3P (390.4): calcd. C 73.83, H 5.94; found C 73.57, H 5.78.
= 20.8 Hz, 2 C), 133.9 (d, JC,P = 20.8 Hz, 2 C), 134.0 (d, JC,P
20.5 Hz, 2 C), 134.0 (d, JC,P = 20.5 Hz, 2 C), 134.0 (d, JC,P
=
=
19.1 Hz), 134.5, 134.5, 134.6 (d, JC,P = 21.0 Hz), 135.2, 137.7, 137.8
(d, JC,P = 10.9 Hz), 137.8 (d, JC,P = 10.9 Hz), 137.9 (d, JC,P
8.0 Hz), 138.0 (d, JC,P = 7.7 Hz), 140.0 (d, JC,P = 26.6 Hz), 140.6
=
(d, JC,P = 26.8 Hz), 166.5 (d, JC,P = 2.2 Hz), 166.9 (d, JC,P
=
2.2 Hz), 199.6, 201.6 ppm. 31P NMR (162.0 MHz, CDCl3) of the
mixture of regioisomers: δ = –4.6, –4.7 ppm. C29H25O3P (452.5):
calcd. C 76.98, H 5.57; found C 76.72, H 5.64.
3-Cyclohexyl-2-formylpropyl o-(Diphenylphosphanyl)benzoate (14):
According to GP 1, hydroformylation of 4 (241 mg, 0.600 mmol)
was carried out with [Rh(CO)2acac] (1.1 mg, 4.2 µmol) in toluene
1
(6 mL), giving 14 (216 mg, 84%). H NMR (400.1 MHz, CDCl3): (2RS,4S)-3-(2Ј,2Ј-Dimethyl-1Ј,3Ј-dioxolan-4Ј-yl)-2-formylpropyl o-
δ = 0.79–2.06 (m, 13 H), 2.67 (ddddd, J = 7.1, 6.9, 6.9, 5.0, 2.1 Hz,
1 H), 4.33 (dd, J = 11.3, 5.2 Hz, 1 H), 4.36 (dd, J = 11.4, 7.1 Hz,
(Diphenylphosphanyl)benzoate (17) (81:19 Mixture of Dia-
stereomers): According to GP 1, hydroformylation of 7 (268 mg,
1 H), 6.89–6.95 (m, 1 H), 7.22–7.42 (m, 12 H), 7.94–7.99 (m, 1 H), 0.600 mmol) was carried out with [Rh(CO)2acac] (1.1 mg,
9.57 (d, J = 2.4 Hz, 1 H) ppm. 13C NMR (100.6 MHz, CDCl3): δ
= 26.1, 26.2, 26.4, 33.3, 33.4, 33.4, 35.0, 48.4, 63.5, 128.4, 128.6 (2
C), 128.6 (2 C), 128.8 (2 C), 130.8 (d, JC,P = 2.7 Hz), 132.2, 134.0
(d, JC,P = 20.5 Hz, 4 C), 134.0 (d, JC,P = 18.6 Hz), 134.5, 137.9 (d,
JC,P = 11.1 Hz), 137.9 (d, JC,P = 10.9 Hz), 140.6 (d, JC,P = 26.8 Hz),
166.6 (d, JC,P = 1.9 Hz), 202.7 ppm. 31P NMR (162.0 MHz,
CDCl3): δ = –4.6 ppm.
4.2 µmol) in toluene (6 mL), giving 17 (269 mg, 94%). 1H NMR
(400.1 MHz, CDCl3): δ = 1.33 (d, J = 0.6 Hz, 3 H), [1.33 (d, J =
0.5 Hz, 3 H)], 1.39 (d, J = 0.5 Hz, 3 H), [1.40 (d, J = 0.5 Hz, 3 H)],
1.66 (ddd, J = 14.2, 9.1, 4.8 Hz, 1 H), 1.98 (ddd, J = 14.2, 8.1,
3.7 Hz, 1 H), 2.80–2.89 (m, 1 H), [3.51 (dd, J = 8.1, 6.8 Hz, 1 H)],
3.52 (dd, J = 8.1, 6.8 Hz, 1 H), [4.04 (dd, J = 8.0, 6.1 Hz, 1 H)],
4.05 (dd, J = 8.1, 6.1 Hz, 1 H), 4.11–4.21 (m, 1 H), 4.48 (dd, J =
2502
www.eurjoc.org
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2007, 2497–2503